Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Descoeur J, Dupuy AM, Bargnoux AS, Cristol JP, Mathieu O.
PMID: 33427019
J Oncol Pharm Pract. 2022 Jan;28(1):55-63. doi: 10.1177/1078155220983407. Epub 2021 Jan 11.

OBJECTIVES: Methotrexate requires therapeutic drug monitoring in oncology because of narrow therapeutic index, especially the metabolite 7-hydroxymethotrexate exhibits nephrotoxicity. The goal of this study was to evaluate different assays and their impact on clinical decisions.METHODS: Following routine measurement with...

Cite
Descoeur J, Dupuy AM, Bargnoux AS, et al. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold. J Oncol Pharm Pract. 2021;28(1):55-63doi: 10.1177/1078155220983407.
Descoeur, J., Dupuy, A. M., Bargnoux, A. S., Cristol, J. P., & Mathieu, O. (2022). Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 28(1), 55-63. https://doi.org/10.1177/1078155220983407
Descoeur, Juliette, et al. "Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 28,1 (2022): 55-63. doi: https://doi.org/10.1177/1078155220983407
Descoeur J, Dupuy AM, Bargnoux AS, Cristol JP, Mathieu O. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold. J Oncol Pharm Pract. 2022 Jan;28(1):55-63. doi: 10.1177/1078155220983407. Epub 2021 Jan 11. PMID: 33427019.
Copy Download .nbib Format: NLM
Evaluation of a new point-of-care testing for creatinine and urea measurement.

Scandinavian journal of clinical and laboratory investigation

Bargnoux AS, Kuster N, Sutra T, Laroche L, Rodriguez A, Morena M, Chenine L, Chalabi L, Dupuy AM, Badiou S, Cristol JP.
PMID: 33908840
Scand J Clin Lab Invest. 2021 Jul;81(4):290-297. doi: 10.1080/00365513.2021.1914344. Epub 2021 Apr 28.

Point of care testing makes it possible to obtain results in an extremely short time. Recently, radiometer has expanded the panel of tests available on its ABL90 FLEX PLUS blood gas analyzer (ABL90) by adding urea and creatinine. The...

Cite
Bargnoux AS, Kuster N, Sutra T, et al. Evaluation of a new point-of-care testing for creatinine and urea measurement. Scand J Clin Lab Invest. 2021;81(4):290-297doi: 10.1080/00365513.2021.1914344.
Bargnoux, A. S., Kuster, N., Sutra, T., Laroche, L., Rodriguez, A., Morena, M., Chenine, L., Chalabi, L., Dupuy, A. M., Badiou, S., & Cristol, J. P. (2021). Evaluation of a new point-of-care testing for creatinine and urea measurement. Scandinavian journal of clinical and laboratory investigation, 81(4), 290-297. https://doi.org/10.1080/00365513.2021.1914344
Bargnoux, Anne-Sophie, et al. "Evaluation of a new point-of-care testing for creatinine and urea measurement." Scandinavian journal of clinical and laboratory investigation vol. 81,4 (2021): 290-297. doi: https://doi.org/10.1080/00365513.2021.1914344
Bargnoux AS, Kuster N, Sutra T, Laroche L, Rodriguez A, Morena M, Chenine L, Chalabi L, Dupuy AM, Badiou S, Cristol JP. Evaluation of a new point-of-care testing for creatinine and urea measurement. Scand J Clin Lab Invest. 2021 Jul;81(4):290-297. doi: 10.1080/00365513.2021.1914344. Epub 2021 Apr 28. PMID: 33908840.
Copy Download .nbib Format: NLM
Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin.

Diagnostics (Basel, Switzerland)

Dupuy AM, Bargnoux AS, Larcher R, Merindol A, Masetto T, Badiou S, Cristol JP.
PMID: 32646054
Diagnostics (Basel). 2020 Jul 07;10(7). doi: 10.3390/diagnostics10070461.

We report the analytical performances of two particle-enhanced (PETIA) methods for measuring procalcitonin (PCT), the Diazyme PCT and the new DiaSys PCT assay, and their concordance of values with BRAHMS PCT Kryptor©. The total imprecisions onto two control levels...

Cite
Dupuy AM, Bargnoux AS, Larcher R, et al. Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin. Diagnostics (Basel). 2020;10(7)doi: 10.3390/diagnostics10070461.
Dupuy, A. M., Bargnoux, A. S., Larcher, R., Merindol, A., Masetto, T., Badiou, S., & Cristol, J. P. (2020). Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin. Diagnostics (Basel, Switzerland), 10(7), . https://doi.org/10.3390/diagnostics10070461
Dupuy, Anne Marie, et al. "Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin." Diagnostics (Basel, Switzerland) vol. 10,7 (2020). doi: https://doi.org/10.3390/diagnostics10070461
Dupuy AM, Bargnoux AS, Larcher R, Merindol A, Masetto T, Badiou S, Cristol JP. Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin. Diagnostics (Basel). 2020 Jul 07;10(7). doi: 10.3390/diagnostics10070461. PMID: 32646054; PMCID: PMC7400370.
Copy Download .nbib Format: NLM
Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score.

Clinical chemistry and laboratory medicine

Dupuy AM, Kuster N, Bargnoux AS, Aguilhon S, Huet F, Leclercq F, Pasquié JL, Roubille F, Cristol JP.
PMID: 33544524
Clin Chem Lab Med. 2021 Feb 04;59(7):1299-1306. doi: 10.1515/cclm-2020-0903. Print 2021 Jun 25.

OBJECTIVES: Inflammation is a hallmark of heart failure (HF) and among inflammatory biomarkers, the most studied remains the C-reactive protein (CRP). In recent years several biomarkers have emerged, such as sST2 and soluble urokinase-type plasminogen activator receptor (suPAR). This...

Cite
Dupuy AM, Kuster N, Bargnoux AS, et al. Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score. Clin Chem Lab Med. 2021;59(7):1299-1306doi: 10.1515/cclm-2020-0903.
Dupuy, A. M., Kuster, N., Bargnoux, A. S., Aguilhon, S., Huet, F., Leclercq, F., Pasquié, J. L., Roubille, F., & Cristol, J. P. (2021). Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score. Clinical chemistry and laboratory medicine, 59(7), 1299-1306. https://doi.org/10.1515/cclm-2020-0903
Dupuy, Anne Marie, et al. "Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score." Clinical chemistry and laboratory medicine vol. 59,7 (2021): 1299-1306. doi: https://doi.org/10.1515/cclm-2020-0903
Dupuy AM, Kuster N, Bargnoux AS, Aguilhon S, Huet F, Leclercq F, Pasquié JL, Roubille F, Cristol JP. Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score. Clin Chem Lab Med. 2021 Feb 04;59(7):1299-1306. doi: 10.1515/cclm-2020-0903. Print 2021 Jun 25. PMID: 33544524.
Copy Download .nbib Format: NLM
Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration.

Artificial organs

Rodriguez A, Morena M, Bargnoux AS, Chenine L, Leray-Moragues H, Cristol JP, Canaud B.
PMID: 33507535
Artif Organs. 2021 Aug;45(8):E280-E292. doi: 10.1111/aor.13923. Epub 2021 Mar 08.

Restoration and maintenance of sodium are still a matter of concern and remains of critical importance to improve the outcomes in homeostasis of stage 5 chronic kidney disease patients on dialysis. Sodium mass balance and fluid volume control rely...

Cite
Rodriguez A, Morena M, Bargnoux AS, et al. Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration. Artif Organs. 2021;45(8):E280-E292doi: 10.1111/aor.13923.
Rodriguez, A., Morena, M., Bargnoux, A. S., Chenine, L., Leray-Moragues, H., Cristol, J. P., & Canaud, B. (2021). Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration. Artificial organs, 45(8), E280-E292. https://doi.org/10.1111/aor.13923
Rodriguez, Annie, et al. "Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration." Artificial organs vol. 45,8 (2021): E280-E292. doi: https://doi.org/10.1111/aor.13923
Rodriguez A, Morena M, Bargnoux AS, Chenine L, Leray-Moragues H, Cristol JP, Canaud B. Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration. Artif Organs. 2021 Aug;45(8):E280-E292. doi: 10.1111/aor.13923. Epub 2021 Mar 08. PMID: 33507535.
Copy Download .nbib Format: NLM
Improved quality of samples and laboratory turnaround time using 3.5 mL low vacuum BD Vacutainer.

Practical laboratory medicine

Badiou S, Vuillot O, Bargnoux AS, Kuster N, Lefebvre S, Sebbane M, Cristol JP, Dupuy AM.
PMID: 31289734
Pract Lab Med. 2019 Jun 12;16:e00128. doi: 10.1016/j.plabm.2019.e00128. eCollection 2019 Aug.

BACKGROUND: Centrifugation is a consuming time step which participates to increase the turnaround time (TAT) in laboratories, likewise hemolysis sample that needs a re-sampling could delay management of patients. Recently, it has been postulated that BD Barricor™ tube could...

Cite
Badiou S, Vuillot O, Bargnoux AS, et al. Improved quality of samples and laboratory turnaround time using 3.5 mL low vacuum BD Vacutainer. Pract Lab Med. 2019;16:e00128doi: 10.1016/j.plabm.2019.e00128.
Badiou, S., Vuillot, O., Bargnoux, A. S., Kuster, N., Lefebvre, S., Sebbane, M., Cristol, J. P., & Dupuy, A. M. (2019). Improved quality of samples and laboratory turnaround time using 3.5 mL low vacuum BD Vacutainer. Practical laboratory medicine, 16e00128. https://doi.org/10.1016/j.plabm.2019.e00128
Badiou, S, et al. "Improved quality of samples and laboratory turnaround time using 3.5 mL low vacuum BD Vacutainer." Practical laboratory medicine vol. 16 (2019): e00128. doi: https://doi.org/10.1016/j.plabm.2019.e00128
Badiou S, Vuillot O, Bargnoux AS, Kuster N, Lefebvre S, Sebbane M, Cristol JP, Dupuy AM. Improved quality of samples and laboratory turnaround time using 3.5 mL low vacuum BD Vacutainer. Pract Lab Med. 2019 Jun 12;16:e00128. doi: 10.1016/j.plabm.2019.e00128. eCollection 2019 Aug. PMID: 31289734; PMCID: PMC6593183.
Copy Download .nbib Format: NLM
Did Creatinine Standardization Give Benefits to the Evaluation of Glomerular Filtration Rate?.

EJIFCC

Piéroni L, Bargnoux AS, Cristol JP, Cavalier E, Delanaye P.
PMID: 29333144
EJIFCC. 2017 Dec 19;28(4):251-257. eCollection 2017 Dec.

During the last decade, a lot of efforts has been made to improve the evaluation of renal functions. Measured Glomerular Filtration Rate (GFR) remains the only valuable test to confirm or confute the status of chronic kidney disease (CKD)...

Cite
Piéroni L, Bargnoux AS, Cristol JP, et al. Did Creatinine Standardization Give Benefits to the Evaluation of Glomerular Filtration Rate?. EJIFCC. 2017;28(4):251-257
Piéroni, L., Bargnoux, A. S., Cristol, J. P., Cavalier, E., & Delanaye, P. (2017). Did Creatinine Standardization Give Benefits to the Evaluation of Glomerular Filtration Rate?. EJIFCC, 28(4), 251-257.
Piéroni, Laurence, et al. "Did Creatinine Standardization Give Benefits to the Evaluation of Glomerular Filtration Rate?." EJIFCC vol. 28,4 (2017): 251-257.
Piéroni L, Bargnoux AS, Cristol JP, Cavalier E, Delanaye P. Did Creatinine Standardization Give Benefits to the Evaluation of Glomerular Filtration Rate?. EJIFCC. 2017 Dec 19;28(4):251-257. eCollection 2017 Dec. PMID: 29333144; PMCID: PMC5746834.
Copy Download .nbib Format: NLM
A Pathway to National Guidelines for Laboratory Diagnostics of Chronic Kidney Disease - Examples from Diverse European Countries.

EJIFCC

Biljak VR, Aakre KM, Yucel D, Bargnoux AS, Cristol JP, Piéroni L.
PMID: 29333148
EJIFCC. 2017 Dec 19;28(4):289-301. eCollection 2017 Dec.

The principal benefit of guidelines is to improve the quality of care received by patients. In the 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (KDIGO) was released and it is designed to provide...

Cite
Biljak VR, Aakre KM, Yucel D, et al. A Pathway to National Guidelines for Laboratory Diagnostics of Chronic Kidney Disease - Examples from Diverse European Countries. EJIFCC. 2017;28(4):289-301
Biljak, V. R., Aakre, K. M., Yucel, D., Bargnoux, A. S., Cristol, J. P., & Piéroni, L. (2017). A Pathway to National Guidelines for Laboratory Diagnostics of Chronic Kidney Disease - Examples from Diverse European Countries. EJIFCC, 28(4), 289-301.
Biljak, Vanja Radišić, et al. "A Pathway to National Guidelines for Laboratory Diagnostics of Chronic Kidney Disease - Examples from Diverse European Countries." EJIFCC vol. 28,4 (2017): 289-301.
Biljak VR, Aakre KM, Yucel D, Bargnoux AS, Cristol JP, Piéroni L. A Pathway to National Guidelines for Laboratory Diagnostics of Chronic Kidney Disease - Examples from Diverse European Countries. EJIFCC. 2017 Dec 19;28(4):289-301. eCollection 2017 Dec. PMID: 29333148; PMCID: PMC5746838.
Copy Download .nbib Format: NLM
Analytical performances of a novel point-of-care procalcitonin assay.

Practical laboratory medicine

Dupuy AM, Bargnoux AS, Andreeva A, Zins C, Kuster N, Badiou S, Cristol JP.
PMID: 31720356
Pract Lab Med. 2019 Oct 26;18:e00145. doi: 10.1016/j.plabm.2019.e00145. eCollection 2020 Jan.

OBJECTIVES: We report the analytical performances of a new point-of-care (POC) procalcitonin (PCT) fluorescence immunoassay that uses the AFIAS-6© system from Boditech and its concordance with results of the standard method Kryptor Compact plus from the central laboratory.DESIGN: and...

Cite
Dupuy AM, Bargnoux AS, Andreeva A, et al. Analytical performances of a novel point-of-care procalcitonin assay. Pract Lab Med. 2019;18:e00145doi: 10.1016/j.plabm.2019.e00145.
Dupuy, A. M., Bargnoux, A. S., Andreeva, A., Zins, C., Kuster, N., Badiou, S., & Cristol, J. P. (2020). Analytical performances of a novel point-of-care procalcitonin assay. Practical laboratory medicine, 18e00145. https://doi.org/10.1016/j.plabm.2019.e00145
Dupuy, Anne Marie, et al. "Analytical performances of a novel point-of-care procalcitonin assay." Practical laboratory medicine vol. 18 (2020): e00145. doi: https://doi.org/10.1016/j.plabm.2019.e00145
Dupuy AM, Bargnoux AS, Andreeva A, Zins C, Kuster N, Badiou S, Cristol JP. Analytical performances of a novel point-of-care procalcitonin assay. Pract Lab Med. 2019 Oct 26;18:e00145. doi: 10.1016/j.plabm.2019.e00145. eCollection 2020 Jan. PMID: 31720356; PMCID: PMC6838538.
Copy Download .nbib Format: NLM
Analytical evaluation of the performances of a new procalcitonin immunoassay.

Clinical chemistry and laboratory medicine

Dupuy AM, Ruffel L, Bargnoux AS, Badiou S, Cristol JP.
PMID: 34800089
Clin Chem Lab Med. 2021 Nov 22; doi: 10.1515/cclm-2021-1019. Epub 2021 Nov 22.

No abstract available.

Cite
Dupuy AM, Ruffel L, Bargnoux AS, et al. Analytical evaluation of the performances of a new procalcitonin immunoassay. Clin Chem Lab Med. 2021;doi: 10.1515/cclm-2021-1019.
Dupuy, A. M., Ruffel, L., Bargnoux, A. S., Badiou, S., & Cristol, J. P. (2021). Analytical evaluation of the performances of a new procalcitonin immunoassay. Clinical chemistry and laboratory medicine, . https://doi.org/10.1515/cclm-2021-1019
Dupuy, Anne Marie, et al. "Analytical evaluation of the performances of a new procalcitonin immunoassay." Clinical chemistry and laboratory medicine vol. (2021). doi: https://doi.org/10.1515/cclm-2021-1019
Dupuy AM, Ruffel L, Bargnoux AS, Badiou S, Cristol JP. Analytical evaluation of the performances of a new procalcitonin immunoassay. Clin Chem Lab Med. 2021 Nov 22; doi: 10.1515/cclm-2021-1019. Epub 2021 Nov 22. PMID: 34800089.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries